Myeloproliferative Neoplasms (MPN)

Dr. Rampal is a hematology-oncology physician who specializes in the treatment of myeloproliferative neoplasms (MPN) and leukemia. He is dedicated to providing my patients with the best possible care, taking into account the individual needs of each patient and his or her family. In addition, Dr. Rampal is an active researcher whose focus is the development of new and innovative approaches to treating MPNs and leukemia. He is working to understand the genetic events that contribute to the development and progression of leukemia and MPNs in the hope of developing new targeted therapies for

After completing Internal Medicine Internship, Residency, and Hematology fellowship at Baylor College of Medicine, Dr. Rice joined the faculty and became a Professor of Medicine and Professor of Thrombosis Research. For more than 20 years, he was the Hematology Program Director and Director of the required medical student Hematology/Oncology course. In 2007, his primary affiliation changed to Chief of Hematology at Houston Methodist Hospital (HMH) and Professor of Medicine at Weill Cornell Medical College. He has maintained an active Consultative Hematology practice at HMH for 40 years. This

Dr. Patel is an Assistant Professor at the University of Nebraska Medical Center. His reasearch interests include: Hematopoietic stem cell transplantation; alternative donors transplant including umbilical cord blood, transplantation of malignant and non-malignant disease.

Dr. Ron Paquette is a member of the Blood and Marrow Transplant Program at Cedars-Sinai. He is a physician and researcher who treats patients with hematologic disorders including aplastic anemia, myelodysplastic syndrome, leukemias and lymphomas. He attended medical school at The Ohio State University, completed his Internal Medicine residency and Hematology-Oncology fellowship at the University of California, Los Angeles. He was previously a faculty member at UCLA before joining Cedars-Sinai Medical Center.

Dr. O’Connell is an academic hematologist with the Jane Anne Nohl Division of Hematology at the Keck School of Medicine of University of Southern California (USC). In addition to her clinical work with patients at the Norris Comprehensive Cancer Center, she conducts clinical and translational research in Myeloproliferative and Myelodysplastic Syndromes (MDS). She is currently the principal investigator at USC on various clinical trials, the most exciting of which is a Phase I trial utilizing a novel hypomethylating agent for patients with MDS and acute myeloid leukemia. This trial is supported

Dr. Pollyea received his MD degree from the University of Chicago Pritzker School of Medicine. He stayed at the University of Chicago Hospital for his residency in Internal Medicine and served as Chief Medical Resident at Cook County Hospital. He then completed his fellowship training in Hematology and Oncology at Stanford University, where he also completed a Masters degree in Epidemiology with an emphasis on biostatistics and clinical trial design. In 2011 he came to the University of Colorado where he is currently the Clinical Director of Leukemia Services. Dr. Pollyea has served as the